Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 85, Issue 1, 2006, Pages 251-254

  Gustofson, Robert L ^a,b,c   Larsen, Frederick W ^b   Bush, Mark R ^b   Segars, James H ^a,b,c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; LEUPRORELIN;

ARTICLE; ESTRADIOL BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; ESTROGENS; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 30344433463     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.07.1291     Document Type: Article

References (25)

1. A. D'Angelo, N. Amso "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev 3 2002 CD002811
2. American Society for Reproductive Medicine Practice Committee Ovarian hyperstimulation syndrome Fertil Steril 82 Suppl 1 2004 S81 S86
3. M. Aboulghar Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS Hum Reprod 18 2003 1140 1141
4. C.D. Chen, M.Y. Wu, K.H. Chao, S.U. Chen, H.N. Ho, Y.S. Yang Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome J Formos Med Assoc 96 1997 829 834
5. R.S. Morris, R.J. Paulson, M.V. Sauer, R.A. Lobo Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome Hum Reprod 10 1995 811 814
6. H.M. Fatemi, P. Platteau, C. Albano, A. Van Steirteghem, P. Devroey Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction Reprod Biomed Online 5 2002 273 275
7. A. Delvigne, C. Carlier, S. Rozenberg Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle? Fertil Steril 76 2001 844 846
8. M.W. Sullivan, A. Stewart-Akers, J.S. Krasnow, S.L. Berga, A.J. Zeleznik Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH) a role for LH in the final stages of follicular maturation J Clin Endocrinol Metab 84 1999 228 232
9. P.E. Egbase, M. Al Sharhan, P. Berlingieri, J.G. Grudzinskas Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment Hum Reprod 15 2000 2082 2086
10. D.V. Tortoriello, P.G. McGovern, J.M. Colon, J.H. Skurnick, K. Lipetz, N. Santoro "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients Fertil Steril 69 1998 454 460
11. M.E. Parsanezhad, S. Alborzi, M. Pakniat, E.H. Schmidt A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome Fertil Steril 80 2003 1151 1155
12. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715
13. D.B. Shapiro, D. Mitchell-Leef, M. Carter, Z.P. Nagy Ganirelix acetate use in normal- and poor-prognosis patients and the impact of estradiol patterns Fertil Steril 83 2005 666 670
14. M.P. Leondires, M. Escalpes, J.H. Segars, R.T. Scott Jr, B.T. Miller Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization Fertil Steril 72 1999 1018 1023
15. J.L. Frattarelli, M.P. Leondires, J.L. McKeeby, B.T. Miller, J.H. Segars Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles a randomized controlled trial Fertil Steril 79 2003 228 230
16. R.H. Asch, H.P. Li, J.P. Balmaceda, L.N. Weckstein, S.C. Stone Severe ovarian hyperstimulation syndrome in assisted reproductive technology definition of high risk groups Hum Reprod 6 1991 1395 1399
17. S. Khosravi, P.C. Leung Differential regulation of gonadotropin-releasing hormone (GnRH)I and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells J Clin Endocrinol Metab 88 2003 663 672
18. P.C. Leung, C.K. Cheng, X.M. Zhu Multi-factorial role of GnRH-I and GnRH-II in the human ovary Mol Cell Endocrinol 202 2003 145 153
19. S.K. Kang, K.C. Choi, H.S. Yang, P.C. Leung Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer Endocr Relat Cancer 10 2003 169 177
20. A. Delvigne, S. Rozenberg A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients Hum Reprod Update 8 2002 291 296
21. U. Ulug, I. Ben-Shlomo, M. Bahceci Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception Fertil Steril 82 2004 338 342
22. V. Isaza, J.A. Garcia-Velasco, M. Aragones, J. Remohi, C. Simon, A. Pellicer Oocyte and embryo quality after coasting the experience from oocyte donation Hum Reprod 17 2002 1777 1782
23. U. Ulug, M. Bahceci, H.F. Erden, E. Shalev, I. Ben-Shlomo The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles Hum Reprod 17 2002 310 313
24. Z. Kilani, A. Dakkak, S. Ghunaim, G.E. Cognigni, C. Tabarelli, L. Parmegiani A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI ovarian response and clinical outcomes Hum Reprod 18 2003 1194 1199
25. M. Filicori, G.E. Cognigni, S. Taraborrelli, D. Spettoli, W. Ciampaglia, C.T. de Fatis Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome J Clin Endocrinol Metab 84 1999 2659 2663